AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Emerging Viruses with Cutaneous Manifestations

Description

The discussion focuses on emerging viruses with cutaneous manifestations, particularly Rubeola, COVID-19, and M-pox. Rubeola, once low in prevalence, has seen a rise due to anti-vaccination sentiments, particularly affecting morbidity and mortality. COVID-19, which originated from coronaviruses, has led to extensive research due to its global impact, including over 600 million cases and substantial mortality. The long-term effects of COVID, known as long COVID, affect approximately 15% of symptomatic patients, with symptoms similar to chronic fatigue syndrome. M-pox emerged as a concern, with a significant number of cases involving men having sex with men, and manifesting differently than in its original context in sub-Saharan Africa. There are effective treatments, including antivirals like Paxlovid for COVID-19 and tecovirimat for M-pox. New viruses like Alaska Pox are also emerging due to climate change, raising public health concerns. The discussion emphasizes the importance of vaccines, public health measures, and awareness to mitigate outbreaks, while noting that not all viruses are harmful; some could serve therapeutic purposes in combating antibiotic resistance. Overall, preparedness is highlighted as crucial for the management of future viral pandemics.

View more

Conclusions

  • The pandemic of COVID-19 is officially over, but the virus persists.
  • Recent monitoring of emerging viruses reveals that measles has reemerged due to declining vaccination rates.
  • The effectiveness of public health measures, antivirals, and vaccine availability is crucial in controlling recent outbreaks of Mpox.
  • Long COVID is reported as a significant sequela in 15% of symptomatic COVID patients, leading to chronic fatigue and other symptoms.
  • Preventative measures, including timely vaccination and treatment protocols, can lessen the impact of both COVID-19 and Mpox.
  • Emerging viruses, such as Alaska pox, pose new challenges partly due to climate change and thawing permafrost.
  • Bacteriophages offer a potential solution for antibiotic-resistant infections and are gaining traction in clinical research and practice.
  • Oncolytic viral therapy is being utilized for certain cancers, showcasing the therapeutic potential of viruses in medicine.
  • Vaccination and proper public health responses can mitigate the risks associated with emerging and reemerging viral diseases.
  • JAMA 329: 701-702; March 7, 2023.
  • Science 379: 745; February 24, 2023.
  • JAMA 329: 781-784; 2023.
  • Thomas S, et al. J Immunother Cancer. 2019;7(1):214.
  • Milhem M, et al. J Clin Oncol. 2022;40(suppl 16):9553.